NiQuitin Citrus (Nicotine Lozenge)
Nicotine replacement therapy for smoking cessation – citrus-flavored lozenges
Quick Facts About NiQuitin Citrus
Key Takeaways About NiQuitin Citrus
- Proven smoking cessation aid: NiQuitin Citrus lozenges are an evidence-based nicotine replacement therapy that can double your chances of quitting smoking compared to willpower alone
- Gradual nicotine delivery: The lozenge dissolves slowly over 20–30 minutes, delivering nicotine through the mouth lining to reduce cravings and withdrawal symptoms
- Structured 12-week program: Use follows a tapering schedule over 12 weeks, gradually reducing the number of lozenges per day to wean you off nicotine
- Choose your strength: Use the 4 mg lozenge if you smoke your first cigarette within 30 minutes of waking; use the 2 mg lozenge if you wait longer than 30 minutes
- Over the counter: Available without a prescription in most countries, making it easily accessible for anyone ready to quit
What Is NiQuitin Citrus and What Is It Used For?
NiQuitin Citrus is a citrus-flavored nicotine lozenge used as nicotine replacement therapy (NRT) to help adults quit smoking. It works by delivering a controlled dose of therapeutic nicotine through the lining of the mouth, reducing the intensity of withdrawal symptoms and cigarette cravings that make quitting so difficult.
Tobacco smoking remains one of the leading preventable causes of death worldwide, responsible for over 8 million deaths each year according to the World Health Organization (WHO). Nicotine, the primary addictive substance in tobacco, creates a powerful physical dependence that makes quitting extremely challenging. Nicotine replacement therapy, including products like NiQuitin Citrus, is one of the most well-studied and effective approaches to smoking cessation.
NiQuitin Citrus belongs to a class of medicines called nicotine replacement therapies (NRTs). These products provide the body with a controlled, lower dose of nicotine without the thousands of harmful chemicals found in cigarette smoke. By partially satisfying the body's nicotine receptors, NRT reduces the severity of withdrawal symptoms such as irritability, anxiety, difficulty concentrating, restlessness, and increased appetite that typically occur when a person stops smoking.
The lozenge formulation offers several advantages. Unlike nicotine patches, which deliver a constant dose throughout the day, lozenges provide on-demand relief that can be used when cravings strike. The citrus flavoring in NiQuitin Citrus was specifically developed to improve taste and palatability compared to unflavored nicotine products, which some users find unpleasant. This improved taste experience may help support adherence to the full treatment program.
NiQuitin Citrus is available in two strengths: 2 mg and 4 mg. The appropriate strength depends on the degree of nicotine dependence, typically assessed by how soon after waking the smoker has their first cigarette. Smokers who light up within 30 minutes of waking are considered highly dependent and should use the 4 mg strength, while those who wait longer than 30 minutes may use the 2 mg strength.
Clinical evidence strongly supports the use of NRT for smoking cessation. A Cochrane systematic review encompassing over 150 randomized controlled trials found that NRT increases the rate of successful long-term quitting by 50–70% compared to placebo or no treatment. NiQuitin Citrus can be used alone or in combination with other NRT products (such as patches) under healthcare professional guidance, a strategy known as combination NRT that has been shown to be more effective than single-product use.
What Should You Know Before Taking NiQuitin Citrus?
Before using NiQuitin Citrus, you should be aware of certain medical conditions, medications, and situations that require caution or medical advice. While NiQuitin Citrus is available over the counter, it is not suitable for everyone, and some people should consult a healthcare professional before starting treatment.
Contraindications
NiQuitin Citrus should not be used by people who are allergic (hypersensitive) to nicotine or any of the other ingredients in the lozenge. It is intended exclusively for current smokers who are committed to quitting and should not be used by non-smokers, occasional smokers, or children under 18 years of age. The product contains nicotine, which is toxic in large doses, and accidental ingestion by children can be life-threatening.
Warnings and Precautions
Consult a healthcare professional before using NiQuitin Citrus if you have any of the following conditions:
- Recent heart attack (within the past 4 weeks) or unstable angina
- Severe cardiac arrhythmias (irregular heartbeat)
- Recent stroke or cerebrovascular event
- Uncontrolled high blood pressure (hypertension)
- Severe liver or kidney disease – nicotine metabolism may be affected
- Active peptic ulcer disease or severe esophagitis – nicotine may worsen symptoms
- Diabetes mellitus – blood sugar levels may change when you stop smoking, potentially requiring insulin dose adjustment
- Overactive thyroid (hyperthyroidism) or pheochromocytoma – nicotine stimulates catecholamine release
- Mouth, throat, or jaw conditions including inflammation, dental problems, or temporomandibular joint (TMJ) disorders
For people with stable cardiovascular disease, the benefits of smoking cessation with NRT generally outweigh the risks of continued smoking. The British National Formulary (BNF) and international guidelines state that NRT is substantially safer than continuing to smoke for patients with heart disease. However, medical supervision is recommended in these cases.
Pregnancy and Breastfeeding
Smoking during pregnancy causes serious harm to the developing baby, including low birth weight, premature birth, placental complications, and increased risk of sudden infant death syndrome (SIDS). Ideally, pregnant women should quit smoking without using any nicotine-containing products.
However, if a pregnant woman is unable to stop smoking without pharmacological support, NRT may be considered under medical supervision. The rationale is that NRT provides nicotine without the carbon monoxide, tar, and thousands of other toxins found in cigarette smoke. Organizations including the UK National Institute for Health and Care Excellence (NICE) and the American College of Obstetricians and Gynecologists (ACOG) acknowledge that NRT may be used in pregnancy when the benefits of quitting outweigh the risks of continued nicotine exposure.
Nicotine passes into breast milk and can affect the nursing infant. If a breastfeeding mother uses NRT, she should try to breastfeed just before using the lozenge and wait as long as possible before the next feeding to minimize the infant's nicotine exposure. Consultation with a healthcare professional is strongly advised.
How Does NiQuitin Citrus Interact with Other Drugs?
Most drug interactions associated with NiQuitin Citrus are actually caused by smoking cessation itself rather than by the nicotine in the lozenge. When you stop smoking, the absence of tobacco smoke chemicals causes changes in how your liver processes certain medications, which can lead to altered drug levels in your blood.
Tobacco smoke contains polycyclic aromatic hydrocarbons that induce the cytochrome P450 enzyme CYP1A2 in the liver. This enzyme is responsible for metabolizing many commonly prescribed medications. When a person stops smoking, CYP1A2 activity decreases over a period of days to weeks, leading to higher blood levels of drugs that are metabolized by this pathway. This is not caused by nicotine itself, but by the removal of the enzyme-inducing chemicals in tobacco smoke.
The clinical significance of this effect varies depending on the medication involved. For some drugs with narrow therapeutic windows, the increase in blood levels can be clinically important and may require dose adjustments. Your prescribing doctor and pharmacist should be informed when you start a smoking cessation program so that appropriate monitoring and dose adjustments can be made.
| Drug | Interaction Type | Clinical Effect | Action Required |
|---|---|---|---|
| Theophylline | CYP1A2 substrate | Plasma levels may increase by up to 100% after smoking cessation | Monitor levels; reduce dose as needed |
| Clozapine | CYP1A2 substrate | Significant increase in plasma levels; risk of toxicity | Monitor closely; mandatory dose reduction |
| Olanzapine | CYP1A2 substrate | Plasma levels may increase; increased sedation | Monitor for side effects; consider dose reduction |
| Warfarin | CYP1A2 substrate | INR may increase; heightened bleeding risk | Monitor INR closely; adjust warfarin dose |
| Insulin | Absorption change | Subcutaneous insulin absorption increases when smoking stops | Monitor blood glucose; adjust insulin dose |
| Caffeine | CYP1A2 substrate | Caffeine levels may rise, causing jitteriness and insomnia | Reduce caffeine intake by 50% |
| Fluvoxamine | CYP1A2 substrate | Plasma levels may increase | Monitor for side effects; consider dose adjustment |
| Ropinirole | CYP1A2 substrate | Plasma levels may increase upon cessation | Monitor; dose reduction may be necessary |
Food and Drink Interactions
The absorption of nicotine from the lozenge through the buccal mucosa is pH-dependent. Acidic substances in the mouth reduce nicotine absorption, which can make the lozenge less effective. For this reason, you should avoid consuming acidic beverages for at least 15 minutes before and during lozenge use. This includes:
- Coffee and tea
- Carbonated soft drinks
- Fruit juices (especially citrus and apple juice)
- Beer, wine, and other alcoholic beverages
Water is acceptable, but you should avoid drinking while the lozenge is actively dissolving in your mouth. Eating while using the lozenge is also not recommended as it interferes with proper buccal absorption.
What Is the Correct Dosage of NiQuitin Citrus?
NiQuitin Citrus follows a structured 12-week tapering program. Start with one lozenge every 1–2 hours during weeks 1–6, reduce to one every 2–4 hours during weeks 7–9, and then one every 4–8 hours during weeks 10–12. Do not exceed 15 lozenges per day.
Choosing the Right Strength
The correct starting strength depends on your level of nicotine dependence, which is assessed using the “time to first cigarette” test:
4 mg Lozenge
Use the 4 mg strength if you smoke your first cigarette within 30 minutes of waking. This indicates high nicotine dependence and you will need a higher nicotine dose to manage withdrawal symptoms effectively.
2 mg Lozenge
Use the 2 mg strength if you wait more than 30 minutes after waking before your first cigarette. This suggests a lower level of physical dependence.
Dosage Schedule
| Treatment Phase | Weeks | Frequency | Max per Day |
|---|---|---|---|
| Phase 1 – Full Dose | Weeks 1–6 | 1 lozenge every 1–2 hours | 15 lozenges |
| Phase 2 – Step Down | Weeks 7–9 | 1 lozenge every 2–4 hours | 15 lozenges |
| Phase 3 – Wean Off | Weeks 10–12 | 1 lozenge every 4–8 hours | 15 lozenges |
How to Use the Lozenge
Proper technique is important for effective nicotine absorption:
- Place the lozenge in your mouth – position it between the gum and cheek, or allow it to dissolve on the tongue
- Let it dissolve slowly – do not chew, crush, or swallow the lozenge. It should dissolve over approximately 20–30 minutes
- Move it occasionally – gently move the lozenge from one side of the mouth to the other from time to time
- Do not eat or drink during use (except water, and not while the lozenge is actively dissolving)
- Avoid acidic drinks for 15 minutes before use, as they reduce nicotine absorption
Adults
The standard dosage schedule described above applies to adults aged 18 years and over. Most smokers use 8–12 lozenges per day during the first six weeks, with the number gradually declining as the program progresses. The minimum effective use is generally considered to be at least 9 lozenges per day during the initial phase. Using too few lozenges may result in inadequate craving control and increased risk of relapse.
Children and Adolescents
NiQuitin Citrus is not recommended for use by individuals under 18 years of age without medical supervision. Adolescent smokers who wish to quit should consult a healthcare professional for personalized advice, as the evidence base for NRT in this age group is more limited. In some countries, pharmacists may supply NRT to adolescents aged 12–17 under supervision.
Elderly Patients
No specific dose adjustment is required for elderly patients. The same 12-week tapering schedule applies. However, older adults may have co-existing medical conditions (cardiovascular disease, renal impairment, hepatic dysfunction) that warrant a discussion with their healthcare provider before starting NRT. The benefits of quitting smoking in older age are well established and include reduced cardiovascular risk and improved respiratory function.
Missed Dose
If you forget to use a lozenge at the scheduled time, use one as soon as you remember. Do not double the dose to make up for a missed one. The key to success is consistent use throughout the day to maintain adequate nicotine levels and prevent breakthrough cravings. If you find yourself frequently forgetting to use the lozenges, consider setting reminders or combining with a nicotine patch for continuous baseline nicotine delivery.
Overdose
Nicotine overdose can occur if too many lozenges are used in a short period, or if lozenges are accidentally ingested by children. Symptoms of nicotine overdose include:
- Nausea, vomiting, and excessive salivation
- Abdominal pain and diarrhea
- Headache, dizziness, and cold sweats
- Tremor and confusion
- Rapid or irregular heartbeat
- Difficulty breathing
- In severe cases: seizures, collapse, and respiratory failure
What Are the Side Effects of NiQuitin Citrus?
Like all medicines, NiQuitin Citrus can cause side effects, although not everybody gets them. Many side effects are similar to those caused by nicotine withdrawal itself, making it difficult to distinguish between product-related effects and cessation symptoms. Most side effects are mild to moderate and tend to diminish with continued use.
It is important to understand that some symptoms you experience when quitting smoking are actually withdrawal symptoms rather than side effects of the lozenge. These include irritability, anxiety, restlessness, difficulty sleeping, increased appetite, and depressed mood. These are normal responses to nicotine withdrawal and typically peak within the first week of quitting before gradually improving over 2–4 weeks.
The side effects listed below are specifically associated with the nicotine lozenge. They are grouped by frequency according to international reporting standards:
Very Common (affects more than 1 in 10 users)
- Nausea
- Hiccups
- Throat irritation or soreness
- Mouth or tongue irritation
- Coughing
Common (affects 1 to 10 in 100 users)
- Headache
- Dizziness
- Indigestion (dyspepsia)
- Abdominal pain or discomfort
- Flatulence
- Dry mouth
- Burning sensation in the mouth
- Taste disturbance
- Increased salivation
- Insomnia (difficulty sleeping)
- Fatigue
Uncommon (affects 1 to 10 in 1,000 users)
- Heart palpitations
- Mouth ulcers
- Flushing
- Skin rash
- Chest discomfort
- Jaw pain or stiffness
- Numbness or tingling in the mouth
Rare (affects fewer than 1 in 1,000 users)
- Allergic reactions (rash, itching, swelling)
- Anaphylaxis (severe allergic reaction)
- Irregular heartbeat (arrhythmias)
- Difficulty swallowing (dysphagia)
- Throat tightness
Many of the common side effects, particularly mouth and throat irritation, are related to the local action of nicotine on the oral mucosa and typically become less bothersome after the first 1–2 weeks of use. Hiccups are a well-known side effect of nicotine lozenges and can sometimes be reduced by using the lozenge more slowly (allowing it to dissolve without excessive movement in the mouth).
If side effects are troublesome or persistent, consult your pharmacist or doctor. Adjusting the frequency of lozenge use or switching to an alternative NRT formulation (such as patches, inhalers, or nasal spray) may provide relief while still supporting your quit attempt.
How Should You Store NiQuitin Citrus?
Store NiQuitin Citrus lozenges at room temperature, below 25°C (77°F), in the original packaging. Keep out of reach and sight of children at all times. Do not use after the expiry date printed on the packaging.
Proper storage ensures the lozenges maintain their effectiveness and safety throughout their shelf life. Key storage guidelines include:
- Temperature: Store below 25°C (77°F). Do not refrigerate or freeze.
- Moisture: Keep lozenges in their original blister packaging until ready for use. Humidity can affect the integrity of the product.
- Light: Protect from direct sunlight and excessive heat.
- Child safety: Always store in a location inaccessible to children. Consider using a lockable medicine cabinet if young children are present in the household.
- Expiry date: Do not use lozenges after the expiry date (EXP) stated on the carton and blister strip. The expiry date refers to the last day of that month.
Do not dispose of medicines via household waste or wastewater. Ask your pharmacist how to dispose of medicines you no longer need. Unused or partially dissolved lozenges should be disposed of safely to prevent accidental exposure, particularly to children and pets. Many pharmacies offer medicine take-back programs for safe disposal.
What Does NiQuitin Citrus Contain?
Each NiQuitin Citrus lozenge contains nicotine (as nicotine resinate/polacrilex) as the active ingredient, available in 2 mg or 4 mg strengths. The lozenges also contain several inactive ingredients that provide structure, flavor, and sweetening.
Active Ingredient
The active substance is nicotine, present as nicotine resinate (also called nicotine polacrilex). This is a complex of nicotine bound to a polacrilin ion-exchange resin, which allows for the controlled, gradual release of nicotine as the lozenge dissolves in the mouth. The 2 mg lozenge delivers approximately 2 mg of nicotine, and the 4 mg lozenge delivers approximately 4 mg of nicotine.
Inactive Ingredients (Excipients)
The inactive ingredients in NiQuitin Citrus lozenges typically include:
- Mannitol – sugar alcohol used as a sweetener and bulk agent
- Sodium alginate – helps with the controlled release of nicotine
- Xanthan gum – thickening agent
- Sodium carbonate – alkalizing agent to optimize nicotine release and absorption
- Sucralose – artificial sweetener
- Acesulfame potassium – artificial sweetener
- Citrus flavoring – provides the characteristic citrus taste
- Magnesium stearate – processing aid
Frequently Asked Questions About NiQuitin Citrus
References
- World Health Organization (WHO). WHO Report on the Global Tobacco Epidemic, 2023. Geneva: WHO; 2023.
- Hartmann-Boyce J, Chepkin SC, Ye W, Bullen C, Lancaster T. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database of Systematic Reviews. 2018;5(5):CD000146. doi:10.1002/14651858.CD000146.pub5
- National Institute for Health and Care Excellence (NICE). Tobacco: preventing uptake, promoting quitting and treating dependence. NICE guideline [NG209]. London: NICE; 2021.
- Lindson N, Chepkin SC, Ye W, Fanshawe TR, Bullen C, Hartmann-Boyce J. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews. 2019;4(4):CD013308. doi:10.1002/14651858.CD013308
- Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database of Systematic Reviews. 2013;(5):CD009329. doi:10.1002/14651858.CD009329.pub2
- British National Formulary (BNF). Nicotine. London: BMJ Group and Pharmaceutical Press; 2025.
- European Medicines Agency (EMA). Summary of Product Characteristics: Nicotine Replacement Therapy Products. Amsterdam: EMA; 2024.
- U.S. Food and Drug Administration (FDA). Nicotine Polacrilex Drug Products for Over-the-Counter Use. Silver Spring: FDA; 2023.
- American College of Obstetricians and Gynecologists (ACOG). Committee Opinion No. 807: Smoking Cessation During Pregnancy. Obstetrics & Gynecology. 2020;135(5):e221–e229.
- Benowitz NL. Nicotine addiction. New England Journal of Medicine. 2010;362(24):2295–2303. doi:10.1056/NEJMra0809890
- Zevin S, Benowitz NL. Drug interactions with tobacco smoking: an update. Clinical Pharmacokinetics. 1999;36(6):425–438. doi:10.2165/00003088-199936060-00004
- World Health Organization (WHO). WHO Guidelines for Smoking Cessation. 2nd edition. Geneva: WHO; 2024.
Editorial Team
Medical Writing
iMedic Medical Editorial Team – Specialists in pharmacology and addiction medicine
Medical Review
iMedic Medical Review Board – Independent expert panel following WHO, NICE, and EMA guidelines
Evidence Framework
GRADE methodology – Level 1A evidence from systematic reviews and meta-analyses
Editorial Standards
No commercial funding or pharmaceutical sponsorship. All content is independent and evidence-based.
This article was written by licensed medical professionals and reviewed according to international standards. For more information about our editorial process, see our editorial standards page. Last medical review: .